Cohort study assesses survival in type 2 diabetes patients with brain metastases related to GLP-1 receptor agonist use, suggesting potential benefits.
This cohort study assesses the association between glucagon-like peptide–1 receptor agonist (GLP-1 RA) use and survival in patients with type 2 diabetes and brain metastases.
No takes yet. Share an insight, caveat, or question.
Chi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: